Sign In
Buy CURE
$90.77
+1.93 (+2.17%)
At Close: Jun 03, 2026
CURE: Pullback In Healthcare Stocks Presents A Buying Opportunity
01:50pm, Wednesday, 08'th Apr 2026
The Direxion Daily Healthcare Bull 3X ETF (CURE) has slipped in early 2026 as investors take profits after a strong performance in late 2025. The correction in healthcare stocks comes even as analysts
Which Sector Topped the Leaderboard for January Returns?
04:41pm, Tuesday, 03'rd Feb 2026
The first month of 2026 is already in the books. Which sector walked away with the top spot when it came to total returns?
CURE: The Leveraged ETF That Turbocharges The Leading U.S. Healthcare Stocks
01:17pm, Friday, 12'th Dec 2025
Direxion Daily Healthcare Bull 3X Shares ETF has surged 83.5% since August 2025, reflecting bullish momentum in healthcare and pharma sectors. Reduced regulatory uncertainty, successful clinical trial
CURE: Analysts Strike A Cautious Tone Heading Into 2026
04:28pm, Wednesday, 26'th Nov 2025
The Direxion Daily Healthcare Bull 3X Shares ETF has meaningfully outperformed the S&P 500 so far in 2025, benefiting from a recent shift in sentiment toward health care stocks. While CURE's underlyin
Direxion's 5 Single-Stock ETFs, Including Coinbase and Robinhood
12:09pm, Thursday, 20'th Nov 2025
Direxion continues to expand its single-stock ETF offerings for tactical traders. It has introduced five new single stock funds that add exposure to Oracle, Coinbase, Robinhood, and Intel.
Top Performing Leveraged/Inverse ETFs: 11/16/2025
01:45pm, Wednesday, 19'th Nov 2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
These Stocks Could Be Catalysts for CURE
09:51am, Tuesday, 04'th Nov 2025
The healthcare sector is catching some flack, and rightfully so. For the three years ending October 15, the S&P Health Care Select Sector Index returned just 22.9%.
Follow Signals, Don't Chase Price - JD Henning
07:00am, Wednesday, 08'th Oct 2025
JD Henning, who runs Value and Momentum Breakouts, shares why following market signals is so important. Leveraging quantitative signals and sector rotation for strong returns.
Direxion's Ultra-Leveraged CURE ETF Offers An Opportunity To Play The Potential Valuation Reset
08:08am, Wednesday, 24'th Sep 2025
Amid rising concerns about stagflation, investors have continued to bid up the equities sector. As evidence, the benchmark S&P 500 sector is up over 13% year-to-date.
Healthcare Sector Could Be on the Comeback Trail
01:33pm, Tuesday, 16'th Sep 2025
Large-cap momentum names have been pushing the healthcare sector aside. Investors have primarily been flocking to Magnificent Seven names benefiting from the artificial intelligence (AI) push.
CURE: Adding Defensive Exposure Amid Frothy Market Valuations
09:36am, Friday, 29'th Aug 2025
The Direxion Daily Healthcare Bull 3X Shares ETF tracks an index composed of U.S. healthcare stocks. While the healthcare sector as a whole is essentially flat in 2025, the effect of beta slippage and
Top Performing Leveraged/Inverse ETFs: 08/17/2025
12:34pm, Tuesday, 19'th Aug 2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
CURE: Make an Adventurous Bet on an Undervalued Sector
09:47am, Tuesday, 12'th Aug 2025
The healthcare sector, the fifth-largest sector exposure in the S&P 500, was once a reliable destination for investors who wanted dependable performance without taking on significant risk. The group h
Top Performing Leveraged/Inverse ETFs: 07/27/2025
04:45pm, Tuesday, 29'th Jul 2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
CURE: A Useful Speculative Tool But Not An Investing Hold
12:29am, Tuesday, 03'rd Jun 2025
CURE is designed for daily 3x leveraged exposure to the healthcare sector, making it suitable for short-term speculation or hedging, not long-term investment. Daily resets and derivatives costs cause
